Cyclacel Pharmaceuticals, Inc. Annual Income Tax Expense (Benefit) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Cyclacel Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
  • Cyclacel Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$210K, a 68.6% increase year-over-year.
  • Cyclacel Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$2.4M, a 42.3% increase year-over-year.
  • Cyclacel Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2023 was -$3M, a 36.5% increase from 2022.
  • Cyclacel Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was -$4.72M, a 26.5% decline from 2021.
  • Cyclacel Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was -$3.73M, a 202% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$3M +$1.72M +36.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 -$4.72M -$989K -26.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 -$3.73M -$2.49M -202% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-11-29
2020 -$1.24M +$60K +4.63% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 -$1.3M +$41K +3.07% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
2018 -$1.34M -$344K -34.6% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-05
2017 -$993K +$990K +49.9% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-28
2016 -$1.98M +$161K +7.51% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-30
2015 -$2.14M +$1.1M +33.9% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-31
2014 -$3.24M -$1.57M -94.2% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-29
2013 -$1.67M -$319K -23.6% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-31
2012 -$1.35M -$786K -139% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-26
2011 -$565K +$92K +14% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-26
2010 -$657K Jan 1, 2010 Dec 31, 2010 10-K 2013-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.